Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

29 studies match

clinicaltrialsPublishedShowing 1–29 of 29 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05006716	A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies(CaDAnCe-101)	recruiting	Phase 1 / Phase 2	645	BeOne MedicinesINDUSTRY	16	Sep 28, 2026	clinicaltrials
NCT02365597	An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer	active not recruiting	Phase 2	239	Janssen Research & Development, LLCINDUSTRY	15	Sep 25, 2026